IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Inde |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Taipei chinois |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Argentine |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Norvège |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
Japon |
30/01/2017 |
10/02/2017 |
|
IP/C/M/84, IP/C/M/84/Add.1 |
1 THE PROTOCOL AMENDING THE TRIPS AGREEMENT – STATUS UPDATE |
United Nations Conference on Trade and Development (UNCTAD) |
30/01/2017 |
10/02/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Inde |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Bangladesh au nom de Pays les moins avancés |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Brésil |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Afrique du Sud |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Chine |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Indonésie |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Nigéria au nom de African Group |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Égypte |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
États-Unis d'Amérique |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Japon |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Canada |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Corée, République de |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Norvège |
01/03/2017-02/03/2017 |
07/06/2017 |
|
IP/C/M/85, IP/C/M/85/Add.1 |
12 THE UNITED NATIONS SECRETARY-GENERAL'S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES |
Union européenne |
01/03/2017-02/03/2017 |
07/06/2017 |
|